The role of A-to-I RNA editing in cancer development

Curr Opin Genet Dev. 2018 Feb:48:51-56. doi: 10.1016/j.gde.2017.10.009. Epub 2017 Nov 8.

Abstract

Adenosine-to-inosine (A-to-I) RNA editing is the most common type of post-transcriptional nucleotide modification in humans, which is catalyzed in ADAR enzymes. Recent genomic studies have revealed thousands of altered RNA editing events in various cancer tissues, leading to diverse functional consequences. A critical role of individual A-to-I RNA editing events in cancer has been reported. Here, we review the current state of our knowledge on key A-to-I RNA editing events in coding and non-coding regions for their roles in cancer development and discuss their potential clinical utility. A better understanding of A-to-I RNA editing and its oncogenic mechanisms may facilitate the development of novel cancer therapeutic strategies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenosine / metabolism*
  • Inosine / metabolism*
  • MicroRNAs / metabolism
  • Neoplasms / genetics*
  • RNA Editing*

Substances

  • MicroRNAs
  • Inosine
  • Adenosine